Concepedia

Sher Karki

SK

34

Publications

5.9K

Citations

30

H-Index

1994

Active since

Affiliations

Xencor (United States)(Current)

University of Pennsylvania

University of Santa Monica

University of Rostock

Christian-Albrechts-Universität zu Kiel

Sher Karki is an author at Xencor (United States) specializing in medicine, cell biology, and immunology.

Top concepts

Publications per year

1994–2018

34

Publications

34

Engineered antibody Fc variants with enhanced effector function

Greg A. Lazar, Wei Dang, Sher Karki et al. · Proceedings of the National Academy of Sciences · 2006 · 783 citations · Full text

, , +13

Enfortumab Vedotin Antibody–Drug Conjugate Targeting Nectin-4 Is a Highly Potent Therapeutic Agent in Multiple Preclinical Cancer Models

Pia M. Challita-Eid, Daulet Satpayev, Peng Yang et al. · Cancer Research · 2016 · 669 citations

Enhanced antibody half-life improves in vivo activity

Jonathan Zalevsky, Aaron K. Chamberlain, Holly M. Horton et al. · Nature Biotechnology · 2010 · 625 citations · Full text

, , +5

Affinity Chromatography Demonstrates a Direct Binding between Cytoplasmic Dynein and the Dynactin Complex

Sher Karki, Erika L.F. Holzbaur · Journal of Biological Chemistry · 1995 · 335 citations · Full text

The p150Glued component of the dynactin complex binds to both microtubules and the actin-related protein centractin (Arp-1).

Clare M. Waterman, Sher Karki, Erika L.F. Holzbaur · Proceedings of the National Academy of Sciences · 1995 · 307 citations · Full text

, , +18

Rows per page

1–5 of 34